2017年9月21日 · The Register of Certificates of Supplementary Protection (CSP) and Applications is maintained pursuant to the Certificate of Supplementary Protection Regulations and the Patent Act.

Canadian Science Publishing (CSP) is Canada’s independent, not-for-profit leader in mobilizing science-based knowledge, making it easy to discover, use, and share.

2023年11月16日 · This guidance document provides an overview of the certificate of supplementary protection (CSP) application process for applicants. This includes information on

2017年9月21日 · Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceutical, biologic and veterinary drugs.

Marginal note: Content of application (3) An application for a certificate of supplementary protection must contain (a) the applicant’s name and contact information in Canada, including their complete address;

2020年10月27日 · As Canada’s CSP system is new, and the early court decisions suggest that the Minister of Health may be interpreting the regulations too narrowly, pharmaceutical innovators should review their pending and granted Canadian patent portfolios carefully, and obtain professional advice to assess whether a CSP may be obtained.

CSP Canada is a specialized underwriter of Accident and Special Risk facultative and treaty reinsurance in Canada. CSP Canada was founded with one objective: to provide responsive solutions to the unique reinsurance needs of our customers.

On May 12, 2023, Health Canada announced the release of an updated version of the Guidance Document: Certificates of Supplementary Protection (CSP Guidance). The CSP Guidance was revised to reflect amendments to the definition of “authorization for sale” in the Certificate of Supplementary Protection Regulations (CSP Regulations) and to ...

2017年7月24日 · CSPs are intended to address lost patent protection due to delays related to fulfilling regulatory requirements and obtaining marketing approvals for a pharmaceutical product encompassed by that patent. The Proposed Regulations are open to public consultation for 15 days following their publication.

Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceuticals, biologics and veterinary drugs"--Introduction, page 7.